Citations

Clear

3030 citation(s) found for "Susan, M".

Establishment of harmonized international reference ranges for plasma estradiol concentrations in postmenopausal women
Cui, Jinghan, Hankinson, Susan E. , Santen, Richard J. , Boutot, Maegan E., Budd, Jeffrey R. , Dowsett, Mitch, Goetz, Matthew P, Guranich, Catherine, Houghton, Serena, Ingle, J , Jones, Micheal E., Rinaldi, Sabina , Rosner, Bernard, Vesper, Hubert W. , Eliassen, A Heather, Swerdlow, Anthony J, Vachon, Celine M. , Richardson, Harriet , Qian, Jing , Jones, Michael E. , Rinaldi, Sabina , Singh, Ravinder J , Vachon, Celine M. , Qian, Jing , Hankinson, Susan E. , Jones, Michael E , Matsumoto, Alvin M. , Dowsett, Mitch , Houghton, Serena C. , Ingle, James N. , Rosner, Bernard A., Schoemaker, Minouk J. , Milne, Roger L. , Swerdlow, Anthony J

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | May 9, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1210/clinem/dgag188 | PMID 42120349 Get It

Abstract Context Prior reports of plasma estradiol concentrations and their reference ranges in postmenopausal women identified marked variation, in part due to assay method and body mass index (BMI). Objective To develop an international reference range for plasma estradiol in postmenopausal women, support accurate assessment of concentrations during systemic and local (eg, vaginal) estradiol therapy, and improve risk prediction for diseases, including osteoporosis, breast, and endometrial cancers. Methodology Estradiol concentrations were measured using primarily liquid chromatography-tandem mass spectrometry (LC-MS/MS) assays in 5 international cohorts of community-dwelling, postmenopausal women of primarily European ancestry aged 38-100 years who were not using exogenous estrogens (n = 7206). Measurements were harmonized to the Centers for Disease Control and Prevention (CDC) reference measurement procedure (RMP) by re-assaying a subset of samples for each cohort and generating recalibration equations. Reference intervals were determined for all women, non-obese women, and specific BMI categories. Results Estradiol concentrations from separate LC-MS/MS assays correlated closely with the CDC RMP, and harmonization minimized inter-assay variability. Estradiol concentrations correlated with BMI but not with chronological age. The reference range (2.5th-97.5th percentile) was 1.1-18.2 pg/mL (4.0-66.8 pmol/L) with median of 4.9 pg/mL (18.0 pmol/L) for all postmenopausal women and 1.1-12.5 pg/mL (4.0-45.9 pmol/L) with median of 4.1 pg/mL (15.1 pmol/L) for non-obese women (BMI < 30). Reference ranges increased progressively with higher BMI categories. Conclusion Cross-calibration of estradiol measurements with the CDC RP enabled the development of harmonized plasma estradiol reference ranges for postmenopausal women who were not using exogenous estrogens, suitable for future studies to establish clinical utility. Increasing obesity in postmenopausal women was associated with increasing estradiol concentration and BMI category-specific reference ranges.
0788 Patient-Bedpartner Subjective Sleep Mismatch in Isolated REM Sleep Behavior Disorder Is Associated with Cognitive Decline and Cortical Thinning
Ha, Jongmok , Bliwise, Donald, Cruz, Hernis de la, Xiong, Chengjie, Ferman, Tanis, Kantarci, Kejal, Lowe, Val, Criswell, Susan, Avidan, Alon, Ju, Yo‐El, Lim, Miranda, Miglis, Mitchell, Postuma, Ronald, Videnovic, Aleksandar, Trotti, Lynn, Miglis, Mitchell G. , Miglis, Mitchell G , Xiong, Chengjie , Kantarci, Kejal , Lowe, Val J. , Criswell, Susan R. , Avidan, Alon Y. , Videnovic, Aleksandar , Trotti, Lynn Marie

Mayo Clinic

SLEEPJ | May 9, 2026 | Volume: 49 | Issue: Supplement_1 | Pages: A353-A353

10.1093/sleep/zsag091.0787 Get It

Abstract Introduction Patients with Parkinson’s disease commonly underreport sleep symptoms, but the extent to which such mismatch may be present in people with isolated RBD (iRBD) is unknown. We evaluated how the patient–bedpartner (PT–BP) mismatch in night-time and daytime sleep complaints relates to cognition, apathy, dopaminergic degeneration, and cortical structure in iRBD. Methods We retrospectively analyzed 425 iRBD participants (2018–2025) from the North American Prodromal Synucleinopathy (NAPS) Consortium with clinicodemographic data, dopamine transporter (DAT) imaging, and magnetic resonance imaging. Using Scales for Outcomes in Parkinson’s Disease (SCOPA)-Sleep, PT–BP mismatch was classified into overestimator (PT>BP), concordant (PT=BP), and underestimator (PT< BP) groups, separately for complaints during night and day. Outcomes included cognition (CDR-Sum of Boxes [CDR-SB], CDR-global, and individual subdomain tests), pareidolia, apathy, subregional DAT uptake, and cortical thickness. Group differences were tested with analysis of covariance adjusting for age, sex, disease duration, education, clinician-rated OSA treatment inadequacy, and the corresponding patient-reported SCOPA-Sleep domain (night or day), and estimated total intracranial volume for cortical thickness; pairwise tests used Bonferroni correction. Results The PT–BP mismatch was common (night – overestimator 127/425, 29.9% and underestimator 116/425, 27.3%; day – overestimator 77/425, 18.1% and underestimator 134/425, 31.5%). For night-time mismatch, underestimators showed lower CDR-SB and lower CDR-global than overestimators. In addition, underestimators exhibited more illusory responses, fewer correct noise rejections, and fewer total correct responses than overestimator and concordant groups. For daytime mismatch, CDR-SB was lower in underestimators versus overestimators; CDR-global was lower in underestimators and concordant participants versus overestimators. No significant associations were found for apathy. Subregional DAT uptake did not differ by mismatch group. Cortical thickness analyses revealed thinner right transverse gyrus in underestimator and concordant groups compared to the overestimator group and thinner left superior temporal gyrus in underestimator group compared to overestimator group, for night-time mismatch only. Conclusion The PT–BP subjective sleep mismatch can be used as a clinical marker associated with overall cognitive decline and cortical thinning in auditory and language processing areas, which may underlie impairment in perceptual interpretation and hallucination proneness. Further research is warranted to seek longitudinal change and phenoconversion in mismatch groups. Support (if any) #U19-AG071754 (NAPS Consortium)
0560 Associations of Late Midlife Sleep-Disordered Breathing with Late-Life Brain Amyloid Deposition
Wu, Mark, Lutsey, Pamela, Jack, Clifford, Yaffe, Kristine, Zipunnikov, Vadim, Wong, Dean, Chand, Ganesh, Bubu, Omonigho, Redline, Susan, Lucey, Brendan, Sharrett, A Richey, Gottesman, Rebecca, Spira, Adam, Jiang, Kening , Lutsey, Pamela L. , Jack, Clifford, Yaffe, Kristine , Zipunnikov, Vadim , Chand, Ganesh B. , Bubu, Omonigho M. , Redline, Susan , Lucey, Brendan P. , Sharrett, A. Richey, Gottesman, Rebecca

Mayo Clinic

SLEEPJ | May 9, 2026 | Volume: 49 | Issue: Supplement_1 | Pages: A249-A249

10.1093/sleep/zsag091.0559 Get It

Abstract Introduction Sleep-disordered breathing (SDB) is a potentially modifiable risk factor for the prevention of dementia, of which Alzheimer’s disease (AD) is the most common cause. However, there is a lack of longitudinal evidence relating SDB to AD pathology >20 years later. We examined the association between late-midlife SDB and late-life brain β-amyloid (Aβ) deposition—a hallmark of AD—assessed approximately 23 years later. Methods The Atherosclerosis Risk in Communities (ARIC) Study is an ongoing prospective cohort study initiated in 1987. Participants at two ARIC sites (Washington County, Maryland; Minneapolis, Minnesota) with primarily White participants also completed polysomnography (PSG) in the Sleep Heart Health Study (SHHS) in 1995-98. SDB measures included apnea-hypopnea index (AHI; number of apneas + hypopneas with ≥3% oxygen desaturation/hour of sleep), arousal index, and percentage of total sleep time in apnea, in hypopnea, and with oxygen saturation < 90%. A subset of participants completed florbetapir positron emission tomography (PET) scans through several ARIC ancillary studies (2011-2025 including the ARIC Sleep-PET study). We defined Aβ deposition as a global standardized uptake value ratio (SUVR) >1.2 (vs. SUVR ≤1.2). We used Poisson regression with robust standard errors to estimate relative risk (RR) of Aβ deposition by SDB, adjusting for demographics and vascular risk factors, and applied inverse probability attrition weighting to account for selective drop-out. Results Among 186 dementia-free participants (mean age=59 years at PSG and 82 years at PET scan, 58% female, 98% White), every 10% increase in total sleep time in hypopnea was associated with higher risk of Aβ deposition (RR=1.40, 95% confidence interval [CI]: 1.03, 1.91). When compared to no SDB (AHI < 5), moderate to severe SDB (AHI ≥15) was associated with elevated Aβ deposition (RR=2.36, 95% CI: 1.22, 4.57); mild SDB (AHI 5 to < 15) was not (RR=1.05, 95% CI: 0.53, 2.07). Conclusion SDB in late midlife was associated with greater risk of Aβ deposition approximately 23 years later. SDB may play a role in the early stages of AD pathogenesis. Future longitudinal studies are needed to optimize strategies for screening and treating SDB for dementia prevention. Support (if any) Supported in part by RF1AG050745.
Web-Based Amblyopia Decision Support Tool
Summers, Allison I. , Hatch, S.W., Wiecek, Emily , Hribar, Michelle R. , Robinson, Julianne L., Chen, Angela M., Kulp, Marjean T., Chen, Debora M. Lee, Repka, Michael X., Roberts, Tawna L. , Wallace, David K. , Vricella, Marilyn, Chang, Steven, Stutz, Kathleen M., Beaulieu, Wesley T., Kraker, Raymond T., Cotter, Susan A., Holmes, Jonathan M., Weise, Katherine K., Pineles, Stacy L., (PEDIG), Pediatric Eye Disease Investigator Group, Hatt, Sarah R. , Chen, Angela M. , Kulp, Marjean Taylor , Repka, Michael X. , Wang, Jingyun, Beaulieu, Wesley T , Kraker, Raymond T. , Cotter, Susan A. , Holmes, Jonathan M.

Mayo Clinic

JAMA Ophthalmology | May 7, 2026 | Volume: 144 | Issue: 6 | Pages: 545

10.1001/jamaophthalmol.2026.1095 | PMID 42096234 Get It

Importance Amblyopia is the leading cause of monocular decreased best-corrected vision in children. Early detection and intervention are key for optimal treatment outcomes; however, limited access to pediatric eye specialists may hinder timely care and affect visual outcomes. Given the shortage of specialty-trained eye care professionals in the US, there is need to support comprehensive eye care professionals who are willing to examine and treat children with amblyopia. Objective A panel from the Pediatric Eye Disease Investigator Group synthesized relevant literature and incorporated consensus opinion where direct evidence was lacking to create the Amblyopia Navigator Decision-Support Instrument, a free, web-based amblyopia decision support tool for eye care professionals. Evidence Review The decisions related to optimal diagnostic measures, pass/refer criteria, and management recommendations were informed by 147 publications. In areas where direct evidence was lacking, guidance was supplemented with clinical trial protocols or existing professional guidelines. When data were conflicting or unavailable, recommendations were established through committee consensus. A single reviewer independently performed standardized (though not systematic) literature reviews to avoid missing pertinent recent publications. Findings Presented are the process used, supporting evidence, and recommendations for testing methods, refractive correction, amblyopia treatment options, treatment adjustments, and monitoring schedules. Conclusions and Relevance Because amblyopia is common and typically responds well to treatment, decision support tools that optimize its management could increase access to pediatric eye care by facilitating earlier detection, enabling broader participation of primary eye care professionals, and ultimately improving visual outcomes. Through this work and the development of the forthcoming free, web-based application version, Amblyopia Navigator Decision-Support Instrument, the Pediatric Eye Disease Investigator Group has created decision support tools designed to assist optometrists and ophthalmologists in the care of children aged 3 to 17 years with amblyopia.
MRI Deep Learning for Differentiating Glioblastoma, IDH Wild-type from Central Nervous System Diffuse Large B-cell Lymphoma
Moassefi, Mana , Decker, Paul A. , Conte, Gian Marco , Kosel, Matthew L., Molinaro, Annette M. , Niederschweiberer, Moritz , Nikanpour, Yalda , Ruff, Michael W. , Burns, Terry C. , Farooq, Umar , Derdeyn, C, Jenkins, RB , Lachance, Daniel H , Eckel‐Passow, Jeanette E. , Kosel, Matthew , Niederschweiberer, Moritz A , Derdeyn, Colin P , Habermann, Thomas , Cerhan, James R , Greenlee, Jeremy D W , Howard, Matthew A , Slager, Susan L , Vaubel, Rachael A , Lachance, Daniel , Erickson, Bradley J , Tobin, W Oliver , Eckel-Passow, Jeanette E , Farooq, Umar , Conte, Gian Marco , Burns, Terry C , Moassefi, Mana , Decker, Paul A. , Kosel, Matthew , Molinaro, Annette M. , Derdeyn, Colin P. , Habermann, Thomas M. , Cerhan, James R. , Greenlee, Jeremy D.W. , Howard, Matthew A. , Slager, Susan L. , Vaubel, Rachael A. , Jenkins, Robert B. , Erickson, Bradley J.

Mayo Clinic

Cancer Research Communications | May 4, 2026 | Volume: 6 | Issue: 5 | Pages: 1168-1179

10.1158/2767-9764.crc-25-0710 | PMID 42081255 Get It

Abstract Glioblastoma (GBM), isocitrate dehydrogenase wild-type (IDHwt) and central nervous system diffuse large B-cell lymphoma (CNS-DLBCL) are aggressive brain tumors with overlapping MRI features, yet distinct treatment approaches. Noninvasive tools are needed to aid in differential diagnosis. Deep learning on T1 postcontrast and T2-weighted MRI sequences were used to differentiate GBM and CNS-DLBCL. A three-stage temporal study design was utilized. Model development was performed on 146 patients with CNS-DLBCL and 146 age-matched, sex-matched, and MRI year–matched patients with GBM diagnosed at Mayo Clinic between 1998 and 2019. Models were tested on independent temporal test cohorts. Initial testing included 240 independent GBM diagnosed at Mayo Clinic between 1998 and 2019. The prospective test cohort included 37 patients with CNS-DLBCL and 256 patients with GBM diagnosed at Mayo Clinic after January 1, 2020, and 36 patients with CNS-DLBCL diagnosed at an external institution. Of the patients diagnosed at Mayo Clinic, 47% had MRIs generated from non-Mayo institutions. Two different model approaches were compared: (i) ensemble approach using area under the receiver operating characteristic curve (AUC) and cross-validation for model selection and (ii) loss approach minimizing cross-entropy loss and cross-validation to evaluate prediction performance. The AUCs on the prospective test cohort were 0.84 [95% confidence interval (CI), 0.78–0.90] and 0.83 (95% CI, 0.77–0.88) for the ensemble and loss approaches, respectively. Stability of ensemble prediction improved with the increasing number of models. Stratified AUC analysis demonstrated consistent performance across sex and age. We utilized a robust temporal study design and applied 2 different analytic approaches to develop a classification model. The findings confirm the feasibility of using MRI-based deep learning models to differentiate GBM from CNS-DLBCL. Significance: GBM, IDHwt and CNS-DLBCL are aggressive brain tumors with overlapping MRI features, yet distinct treatment approaches. Noninvasive tools are needed to aid in differential diagnosis. We developed MRI-based deep learning models to differentiate GBM, IDHwt from CNS-DLBCL using a rigorous three-stage temporal design that included prospective validation. The model AUC on a prospective cohort was 0.84.
Correction to: Abdominal Symptom Improvement During Clinical Trials of Tenapanor in Patients With Irritable Bowel Syndrome With Constipation: A Post Hoc Analysis
Lembo, Anthony J, Chey, W D, Harris, Lucinda A. , Frazier, Rosita, Brenner, Darren M., Chang, Lin, Lacy, Brian E., Edelstein, Susan, Yang, Yang, Zhao, Suling , Rosenbaum, David P. , Lembo, Anthony , Chey, William D. , Frazier, Rosita , Brenner, Darren M. , Chang, Lin , Lacy, Brian E. , Edelstein, Susan , Yang, Yang

Mayo Clinic

American Journal of Gastroenterology | May 4, 2026 | Volume: 121 | Issue: 7 | Pages: 1787-1787

10.14309/ajg.0000000000004025 | PMID 42080433 Get It

At‐home visual acuity in children using a custom iPhone application compared with standardized in‐office visual acuity testing
Roberts, Tawna L. , Bothun, Erick D. , Zhu, Yufeng, Henderson, Robert J. , Boyle, Nicole M, Leske, David A. , Wernimont, Suzanne M., Marino, Carrie E, Manh, Vivian M. , Youngerman, Jillian M, Qayum, Jennifer N, Srinivasan, Gayathri , Titelbaum, Jenna R. , Crouch, Eric R. , Colburn, Jeffrey, Esposito, Christina , Zeto, V Lori, Connolly, Katie, Bhakta, Rita M, Lorenzana, Ingryd J., McDowell, Paula, Beaulieu, Wesley T, Kraker, Raymond T, Holmes, Jonathan M, Pineles, Stacy L., Weise, Katherine K., Cotter, Susan A, Group, Pediatric Eye Disease Investigator, Beaulieu, Wesley T , Kraker, Raymond T , Hatt, Sarah R. , Raghuram, Aparna , McDowell, Paula S., Kraker, Raymond T. , Holmes, Jonathan M. , Cotter, Susan A.

Mayo Clinic

Optometry and Vision Science | May 1, 2026 | Volume: 103 | Issue: 4 | Pages: No page available

10.1002/ovs2.70040 | PMID 42062237 Get It

ABSTRACT Purpose To validate a custom smartphone application for at‐home visual acuity (VA) measurement in children. Methods A total of 452 children aged 3–17.5 years participated. Certified examiners measured in‐office test–retest VA (logMAR) using gold‐standard Amblyopia Treatment Study HOTV (3‐to‐6‐year‐olds, younger cohort) or electronic Early Treatment of Diabetic Retinopathy Study (7‐to‐17.5‐year‐olds, older cohort) protocols at 3–4.5 m and app‐based VA at 1.5 m. Caregivers measured at‐home app‐based VA at 1.5 m. Results Comparing at‐home app‐based with gold‐standard VA, in eyes 20/40 or better, 95% (143/151) and 93% (91/98) of the younger and older cohorts were within 2 lines, respectively (mean differences: younger = −0.03, older = −0.04; 95% limits‐of‐agreement half‐width (LOA): younger = ±0.26, older = ±0.22). In eyes 20/50 or worse, 66% (42/64) and 75% (76/101) of the younger and older cohorts were within 2 lines, respectively (mean differences: younger = 0.11, older = 0.13, LOA: younger = ±0.50, older = ±0.51). Comparing in‐office app‐based VA with gold‐standard VA, in eyes 20/40 or better, 98% (160/164) and 94% (99/105) of the younger and older cohorts were within 2 lines, respectively (mean differences: younger = −0.03, older = −0.03; LOA: younger = ±0.22; older = ±0.24). In eyes 20/50 or worse, 85% (60/71) and 91% (101/111) of the younger and older cohorts were within 2 lines, respectively (mean differences: younger = 0.04; older = 0.04; LOA: younger = ±0.39; older = ±0.24). For gold‐standard test–retest, in eyes 20/40 or better, 99% (163/164) and 99% (104/105) of the younger and older cohorts had retest within 2 lines, respectively (mean differences: younger = 0.00; older = 0.01; LOA: younger = ±0.17; older = ±0.11). For 20/50 or worse, 92% (66/72) and 100% (111/111) in the younger and older cohorts were within 2 lines, respectively (mean differences: younger = 0.01; older = 0.02; LOA: younger = ±0.35; older = ±0.15). Conclusions Our app demonstrated good concordance with the gold standard at home and in the office for eyes with VA of 20/40 or better. However, concordance decreased considerably for eyes with VA 20/50 or worse, particularly at home.
Procedural Competence Among Academic Emergency Medicine Attending Physicians: A Survey of Skill Maintenance Strategies
Raukar, Neha P. , Rockwell, Maya R., Caretta‐Weyer, Holly , Promes, Susan B., Santen, Sally A , Caretta-Weyer, Holly A , Raukar, Neha , Promes, Susan B.

Mayo Clinic

AEM Education and Training | April 30, 2026 | Volume: 10 | Issue: 2 | Pages: No page available

10.1002/aet2.70164 | PMID 42078479 Get It

ABSTRACT Objectives To evaluate how academic emergency departments (EDs) support procedural skill maintenance for faculty physicians, particularly in environments where learners often perform procedures. We aimed to characterize training strategies, barriers to participation, and the inclusion of high‐acuity, low‐occurrence (HALO) procedures. Methods We conducted a cross‐sectional survey of department chairs, vice chairs, and chair emeriti attending the 2025 Association of Academic Chairs of Emergency Medicine (AACEM) retreat. The survey assessed institutional approaches to procedural training, frequency of offerings, training modalities, inclusion of HALO procedures, and perceived barriers. Descriptive statistics and chi‐square tests were used to analyze differences in training frequency and procedural coverage. Results Of 81 academic departments represented, 49 responded (60.5%). Most (87.8%) offered procedural training, yet only 32.6% required participation. Hands‐on training was most common (93%), followed by in‐person (79%) and virtual (16%) sessions. While 100% of departments covered point‐of‐care ultrasound and 93% airway management, fewer addressed HALO procedures: only 27.9% covered all HALO categories (e.g., surgical airway, thoracostomy, pericardiocentesis). Time constraints and clinical schedules were the most‐commonly reported barriers to participation. Conclusions Procedural skill maintenance for EM attendings varies widely across academic EDs. Despite the specialty's procedural intensity, most academic departments lack comprehensive, mandatory training, particularly for infrequent but critical procedures. Findings highlight variability in departmental approaches and the need to further explore best practices for procedural skill maintenance.
AMCP Market Insights: Getting to the heart of hard-to-control hypertension in managed care
Flavin, Bridget, Wolff, Denise, Gandhi, Gaurang, Pourarsalan, Hiva, Rader, Florian, Richardson, T, Shannon, Michael, Spence, Stephanie, Wescott, Susan, Flavin, Bridget M., Gandhi, Gaurang, Rader, Florian , Richardson, Terry, Shannon, Michael H.

Mayo Clinic

Journal of Managed Care & Specialty Pharmacy | April 27, 2026 | Volume: 32 | Issue: 5-a Suppl | Pages: S1-S10

10.18553/jmcp.2026.32.5-a.s1 | PMID 42044060 Get It